TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Chiron Pharmasynth AS
Closing information (x1000 NOK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 10,978 | 7,036 | 8,100 |
Financial expenses | 28 | 55 | 133 |
Earnings before taxes | 3,421 | 2,030 | 4,499 |
Total assets | 16,811 | 12,720 | 11,241 |
Current assets | 16,781 | 12,672 | 11,145 |
Current liabilities | 5,021 | 4,351 | 4,902 |
Equity capital | 11,791 | 8,369 | 6,339 |
- share capital | 1,775 | 1,775 | 1,775 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 70.1% | 65.8% | 56.4% |
Turnover per employee | |||
Profit as a percentage of turnover | 31.2% | 28.9% | 55.5% |
Return on assets (ROA) | 20.5% | 16.4% | 41.2% |
Current ratio | 334.2% | 291.2% | 227.4% |
Return on equity (ROE) | 29.0% | 24.3% | 71.0% |
Change turnover | 3,942 | -1,064 | 3,197 |
Change turnover % | 56% | -13% | 65% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.